Evogene Stock Five Year Return
| EVGN Stock | ILA 599.80 0.20 0.03% |
Evogene fundamentals help investors to digest information that contributes to Evogene's financial success or failures. It also enables traders to predict the movement of Evogene Stock. The fundamental analysis module provides a way to measure Evogene's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Evogene stock.
Evogene |
Evogene Company Five Year Return Analysis
Evogene's Five Year Return is considered one of the best measures to evaluate fund performance, especially from the mid and long term perspective. It shows the total annualized return generated from holding equity for the last five years and represents capital appreciation of the investment, including all dividends, losses, and capital gains distributions.
More About Five Year Return | All Equity Analysis
Five Year Return | = | (Mean of Monthly Returns - 1) | X | 100% |
Although Five Year Returns can give a sense of overall investment potential, it is recommended to compare equity performance with similar assets for the same five year time interval. Similarly, comparing overall investment performance over the last five years with the appropriate market index is a great way to determine how this equity instrument will perform during unforeseen market fluctuations.
| Competition |
According to the company disclosure, Evogene has a Five Year Return of 0.0%. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all Israel stocks average (which is currently at 0.0).
Did you try this?
Run Risk-Return Analysis Now
Risk-Return AnalysisView associations between returns expected from investment and the risk you assume |
| All Next | Launch Module |
Evogene Fundamentals
| Return On Equity | -0.63 | |||
| Return On Asset | -0.28 | |||
| Operating Margin | (24.02) % | |||
| Current Valuation | 8.8 M | |||
| Shares Outstanding | 41.22 M | |||
| Shares Owned By Insiders | 3.58 % | |||
| Shares Owned By Institutions | 3.37 % | |||
| Price To Book | 0.93 X | |||
| Price To Sales | 73.01 X | |||
| Revenue | 930 K | |||
| Gross Profit | 163 K | |||
| EBITDA | (26.78 M) | |||
| Net Income | (27.79 M) | |||
| Cash And Equivalents | 65.36 M | |||
| Cash Per Share | 1.61 X | |||
| Total Debt | 2.39 M | |||
| Debt To Equity | 0.03 % | |||
| Current Ratio | 12.74 X | |||
| Book Value Per Share | 0.74 X | |||
| Cash Flow From Operations | (24.72 M) | |||
| Earnings Per Share | (0.72) X | |||
| Target Price | 5.0 | |||
| Number Of Employees | 133 | |||
| Beta | 0.9 | |||
| Market Capitalization | 121.59 M | |||
| Total Asset | 76.3 M | |||
| Retained Earnings | (90 M) | |||
| Working Capital | 89 M | |||
| Current Asset | 95 M | |||
| Current Liabilities | 6 M | |||
| Z Score | 29.8 | |||
| Net Asset | 76.3 M |
About Evogene Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Evogene's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Evogene using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Evogene based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Information and Resources on Investing in Evogene Stock
When determining whether Evogene offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Evogene's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Evogene Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Evogene Stock:Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Evogene. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade Evogene Stock refer to our How to Trade Evogene Stock guide.You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.